The Drugs Technical Advisory Board (DTAB) under the central drug regulatory authority has recommended doing away with the requirement of a prescription for buying Refresh Tears, a medicine for dry ...

The Drugs Technical Advisory Board (DTAB) has recommended amendment of the Rules to change Allergan India’s Refresh Tears eye drops from prescription drug to over-the-counter drug, in line with the ...